SLC2A1 and neoplasm: (16) demonstrated that miRNA-328 could inhibit the solute carrier family 2 member 1 (SLC2A1), which encodes the GLUT1 protein, thus downregulating the expression of GLUT1 in tumors and inhibiting tumor proliferation.